1. Academic Validation
  2. A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis

A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis

  • Cancer Cell. 2002 Oct;2(4):335-46. doi: 10.1016/s1535-6108(02)00152-6.
Hisako Higashitsuji 1 Hiroaki Higashitsuji Toshikazu Nagao Kohsuke Nonoguchi Shingo Fujii Katsuhiko Itoh Jun Fujita
Affiliations

Affiliation

  • 1 Department of Clinical Molecular Biology, Faculty of Medicine, Kyoto University, 54 shogoin Kawaharacho, Sakyo-ku, 606-8507, Kyoto, Japan.
Abstract

NF-kappa B is a transcription factor that can protect from or contribute to Apoptosis. Here we report identification of HSCO that binds to NF-kappa B and inhibits Apoptosis. HSCO mRNA was overexpressed in 20 of 30 hepatocellular carcinomas analyzed. Overexpression of HSCO inhibited Caspase 9 activation and Apoptosis induced by DNA damaging agents, while it augmented Apoptosis induced by TNFalpha. Like I kappa B alpha, HSCO inhibited NF-kappa B activity and abrogated p53-induced Apoptosis. However, the underlying mechanism was different. HSCO is a nuclear-cytoplasmic shuttling protein, bound to RelA NF-kappa B, and HSCO sequestered it in the cytoplasm by accelerating its export from the nucleus. These results suggest that overexpression of HSCO suppresses p53-induced Apoptosis by preventing nuclear localization of NF-kappa B during signaling and thus contributes to hepatocarcinogenesis.

Figures